Recombinant Zoster vaccine (CHO cells) (Anhui Zhifei Longcom Biopharma)

重组带状疱疹疫苗（CHO细胞）（安徽智飞龙科马生物制药）

Report date: 2025/07/08 17:20:19

Base Information

Drug NameRecombinant Zoster vaccine (CHO cells) (Anhui Zhifei Longcom Biopharma)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Zoster

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsHerpes Zoster

Inactive IndicationsN/A

Other Information

ATC CodeN/A